Cargando…
Strategies for active and passive pediatric RSV immunization
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vaccines. Difficulties in RSV vaccine development stem...
Autores principales: | Eichinger, Katherine M., Kosanovich, Jessica L., Lipp, Madeline, Empey, Kerry M., Petrovsky, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879001/ https://www.ncbi.nlm.nih.gov/pubmed/33623860 http://dx.doi.org/10.1177/2515135520981516 |
Ejemplares similares
-
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection
por: Eichinger, Katherine M., et al.
Publicado: (2020) -
Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation
por: Eichinger, Katherine M., et al.
Publicado: (2022) -
Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams
por: Kosanovich, Jessica L., et al.
Publicado: (2023) -
Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
por: Eichinger, Katherine M., et al.
Publicado: (2017) -
RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice
por: Killian, Katherine N., et al.
Publicado: (2023)